HUTCHMED (China) (HCM) Enterprise Value (2014 - 2025)
HUTCHMED (China)'s (HCM) quarterly Enterprise Value came in at -$174.1 million in Q4 2025, up 100.0% year-on-year from -$87.0 million in Q4 2024, and up 87.12% on a QoQ basis from -$1.4 billion in Q2 2025.
HUTCHMED (China) (HCM) Enterprise Value (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 12 years of Enterprise Value data on file, last reported at -$174.1 million in Q4 2025.
- On a quarterly basis, Enterprise Value rose 100.0% year-over-year to -$174.1 million in Q4 2025; TTM through Dec 2025 was -$174.1 million, a 100.0% increase from a year earlier, with the FY2025 full-year figure at -$174.1 million, up 100.0% from the prior year.
- Enterprise Value for Q4 2025 stood at -$174.1 million, up from -$1.4 billion in the prior quarter.
- Over the last five years, Enterprise Value for HCM reached as high as $1.6 billion in Q4 2023 and fell as low as -$107549.6 billion in Q4 2024.
- Historically, Enterprise Value has averaged -$9777.6 billion across 5 years, with a median of -$774.1 million in 2022.
- Across the five-year window, Enterprise Value jumped 2227.31% in 2023 and sank 6542348.44% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$123.1 million in 2021, then surged by 37.24% to -$77.3 million in 2022, then soared by 2227.31% to $1.6 billion in 2023, then sank by 6542348.44% to -$107549.6 billion in 2024, then jumped by 100.0% to -$174.1 million in 2025.
- Per Business Quant data, the three most recent Enterprise Value figures were -$174.1 million in Q4 2025, -$1.4 billion in Q2 2025, and -$107549.6 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | -174.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -174.08 Mn |
| Jun 30, 2025 | -1.35 Bn |
| Dec 31, 2024 | -107,549.61 Bn |
| Jun 30, 2024 | -790.52 Mn |
| Dec 31, 2023 | 1.64 Bn |
| Jun 30, 2023 | -838.19 Mn |
| Dec 31, 2022 | -77.28 Mn |
| Jun 30, 2022 | -774.08 Mn |
| Dec 31, 2021 | -123.12 Mn |
| Jun 30, 2021 | -921.55 Mn |
| Mar 31, 2021 | -359.95 Mn |
| Dec 31, 2020 | -435.18 Mn |
| Jun 30, 2020 | -256.09 Mn |
| Dec 31, 2019 | -217.17 Mn |
| Sep 30, 2019 | -177.31 Mn |
| Jun 30, 2019 | -212.14 Mn |
| Mar 31, 2019 | -247.28 Mn |
| Dec 31, 2018 | -277.69 Mn |
| Jun 30, 2018 | -296.38 Mn |
| Dec 31, 2017 | -335.06 Mn |